Published in Nature on April 10, 1980
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
Caspases: the executioners of apoptosis. Biochem J (1997) 11.99
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell (2000) 8.95
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
The extracellular matrix as a cell survival factor. Mol Biol Cell (1993) 6.32
Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun (2005) 6.31
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med (1997) 5.53
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci U S A (1996) 5.03
Endogenous endonuclease-induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci U S A (1983) 4.81
Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol (2014) 4.76
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med (1993) 4.53
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest (1992) 4.40
Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol (1994) 4.36
Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest (1994) 4.28
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol (1992) 4.17
Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol (1995) 4.00
Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin. J Exp Med (1994) 3.94
A yeast mutant showing diagnostic markers of early and late apoptosis. J Cell Biol (1997) 3.79
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer (2009) 3.45
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ (2009) 3.44
Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A (1997) 3.43
Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med (1992) 3.40
The molecular biology of apoptosis. Proc Natl Acad Sci U S A (1996) 3.39
Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J (1992) 3.23
RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature (2007) 3.21
An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A (2000) 3.13
Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci U S A (1995) 3.13
Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci U S A (2011) 3.11
Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol (1997) 3.03
Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest (1991) 2.82
A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol (2005) 2.77
Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology (1985) 2.77
Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J Virol (1991) 2.71
Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med (1994) 2.71
Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol (1993) 2.67
Caspase-dependent conversion of Dicer ribonuclease into a death-promoting deoxyribonuclease. Science (2010) 2.66
Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol (1994) 2.63
Intracellular Staphylococcus aureus escapes the endosome and induces apoptosis in epithelial cells. Infect Immun (1998) 2.63
Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A (1994) 2.58
Antibiotic-induced bacterial cell death exhibits physiological and biochemical hallmarks of apoptosis. Mol Cell (2012) 2.56
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol (1995) 2.55
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A (1992) 2.54
Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J (1993) 2.50
Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest (1999) 2.48
Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J (1996) 2.46
Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J (1994) 2.43
Salt stress-induced cell death in the unicellular green alga Micrasterias denticulata. J Exp Bot (2009) 2.39
Identification and functional characterization of a TIA-1-related nucleolysin. Proc Natl Acad Sci U S A (1992) 2.38
The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc Natl Acad Sci U S A (1998) 2.38
A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest (1997) 2.37
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci U S A (1994) 2.37
Do all programmed cell deaths occur via apoptosis? Proc Natl Acad Sci U S A (1993) 2.35
Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci U S A (1995) 2.27
Apoptosis (the 1992 Frank Rose Memorial Lecture). Br J Cancer (1993) 2.20
The CARD-carrying caspase Dronc is essential for most, but not all, developmental cell death in Drosophila. Development (2005) 2.19
Formation of apoptosome is initiated by cytochrome c-induced dATP hydrolysis and subsequent nucleotide exchange on Apaf-1. Proc Natl Acad Sci U S A (2005) 2.18
Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A (1991) 2.13
Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer (2000) 2.12
Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol (1994) 2.06
Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J (1994) 2.05
Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol (1982) 2.04
Drug-target interactions: only the first step in the commitment to a programmed cell death? Br J Cancer (1991) 2.01
Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol (1989) 1.98
Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97
Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J Cell Biol (1994) 1.96
Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci U S A (1996) 1.95
Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol (1995) 1.95
Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J (1990) 1.94
Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med (1989) 1.91
Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol (1991) 1.88
Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol (1998) 1.87
Staphylococcus aureus Agr and Sar global regulators influence internalization and induction of apoptosis. Infect Immun (1998) 1.86
T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol Cell Biol (1997) 1.85
Cell-free reconstitution of Fas-, UV radiation- and ceramide-induced apoptosis. EMBO J (1995) 1.85
Presence of double-strand breaks with single-base 3' overhangs in cells undergoing apoptosis but not necrosis. J Cell Biol (1996) 1.85
Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J (1995) 1.84
Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J Exp Med (1994) 1.83
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest (1995) 1.81
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med (1995) 1.80
Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol (1991) 1.80
Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol (1992) 1.80
Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol (1991) 1.80
Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J Virol (1992) 1.79
Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol (1995) 1.78
Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev (2005) 1.76
Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol (1994) 1.75
E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol (1998) 1.75
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Aurintricarboxylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity. J Cell Biol (1991) 1.68
Necrotic death pathway in Fas receptor signaling. J Cell Biol (2000) 1.68
Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med (1992) 1.65
Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals. J Cell Biol (1995) 1.64
NUC-1, a caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis. Genes Dev (2000) 1.63
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer (1972) 35.74
Cell death: the significance of apoptosis. Int Rev Cytol (1980) 24.88
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (1993) 10.72
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
Apoptosis. The role of the endonuclease. Am J Pathol (1990) 5.43
Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol (1991) 4.89
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys (1989) 3.07
Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med (1995) 3.07
Defying death after DNA damage. Nature (2000) 3.03
Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology (1985) 2.77
Selective DNA conservation and chromatin assembly after injection of SV40 DNA into Xenopus oocytes. Dev Biol (1978) 2.43
Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta (1992) 2.33
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol (1982) 2.04
Accuracy of reporting of family history of colorectal cancer. Gut (2004) 1.92
Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene (1994) 1.91
Microsatellite instability and the role of hMSH2 in sporadic colorectalcancer. Oncogene (1996) 1.89
Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc Natl Acad Sci U S A (2001) 1.85
Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (1993) 1.84
Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol (1984) 1.83
The Edinburgh intercalated honours BSc in pathology: evaluation of selection methods, undergraduate performance, and postgraduate career. Br Med J (Clin Res Ed) (1986) 1.82
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet (1991) 1.77
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogene (1994) 1.69
High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22. Oncogene (1989) 1.52
The biology of cell death in tumours. Anticancer Res (1985) 1.51
Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol (1994) 1.50
Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene (1993) 1.50
MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. Oncogene (1991) 1.49
Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res (1996) 1.49
Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol (1995) 1.48
APC expression in normal human tissues. J Pathol (1997) 1.44
Papillomaviruses and human cancer. Hum Pathol (1990) 1.43
Familial adenomatous polyposis coli in South Africa--molecular basis and diagnosis. S Afr Med J (2000) 1.39
Detection of mutations associated with colorectal cancer in DNA from whole-gut lavage fluid. J Natl Cancer Inst (1998) 1.38
Adrenocortical cell deletion: the role of ACTH. J Pathol (1973) 1.37
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc Natl Acad Sci U S A (1999) 1.33
Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene (1999) 1.32
HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol (1991) 1.30
Chromatin assembly and transcription in eggs and oocytes of Xenopus laevis. Cold Spring Harb Symp Quant Biol (1978) 1.26
Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene (1999) 1.24
P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene (1999) 1.23
New insights into the role of PML in tumour suppression. Cell Res (2008) 1.22
The CAG repeat within the androgen receptor gene in male breast cancer patients. J Med Genet (2000) 1.22
Human papillomavirus type 18 associates with more advanced cervical neoplasia than human papillomavirus type 16. Hum Pathol (1993) 1.21
Death and the cell. Immunol Today (1986) 1.20
Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer (1999) 1.19
Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer (1993) 1.19
Stimulation of endogenous endonuclease activity in hepatocytes exposed to oxidative stress. Toxicol Lett (1988) 1.18
Chromatin changes in apoptosis. Histochem J (1981) 1.17
Genetic linkage map of six polymorphic DNA markers around the gene for familial adenomatous polyposis on chromosome 5. Am J Hum Genet (1990) 1.17
Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene (1993) 1.15
Apoptosis. Death gets a brake. Nature (1994) 1.15
Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer (1985) 1.15
DNA chip technology. J Pathol (1999) 1.13
The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J Pathol (1997) 1.12
Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis. Genes Chromosomes Cancer (1996) 1.11
Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene (1997) 1.11
What is apoptosis? Histopathology (1986) 1.10
Frequent microsatellite instability and mismatch repair gene mutations in young Chinese patients with colorectal cancer. J Natl Cancer Inst (1999) 1.09
A study of stabilisation of p53 protein versus point mutation in colorectal carcinoma. Oncogene (1994) 1.07
Colorectal carcinoma in Hong Kong: epidemiology and genetic mutations. Br J Cancer (1997) 1.05
Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer (1993) 1.04
Cell death in the normal neonatal rat adrenal cortex. J Pathol (1973) 1.04
Apoptosis: cell death under homeostatic control. Arch Toxicol Suppl (1987) 0.98
N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions. Gut (1997) 0.97
Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene (2001) 0.96
Nuclear localisation of an oocyte component required for the stability of injected DNA. Nature (1977) 0.96
Apoptosis: an overview of the process and its relevance in disease. Adv Pharmacol (1997) 0.96
p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ (2001) 0.95
Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients. Clin Sci (Lond) (1984) 0.95
APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer (1994) 0.95
Specific patterns of chromosomal abnormalities are associated with RER status in sporadic colorectal cancer. J Pathol (2000) 0.93
Ras p21 in breast tissue: associations with pathology and cellular localisation. Br J Cancer (1992) 0.93
Linkage analysis in familial adenomatous polyposis: order of C11P11 (D5S71) and pi 227 (D5S37) loci at the apc gene. Genomics (1989) 0.92
A polymorphism in the CYP17 gene is associated with male breast cancer. Br J Cancer (1999) 0.92
Human papillomavirus type 18 is associated with less apoptosis in fibroblast tumours than human papillomavirus type 16. Br J Cancer (1995) 0.92
p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer (1995) 0.91
p53-independent DNA repair and cell cycle arrest in embryonic stem cells. FEBS Lett (1998) 0.91
SspI polymorphism in sequence encoding 3' untranslated region of the APC gene. Nucleic Acids Res (1991) 0.90
Inhibition of human T lymphocyte colony formation by methylprednisolone. Clin Exp Immunol (1981) 0.90
Evidence for the receipt of DNA damage stimuli by PML nuclear domains. J Pathol (2007) 0.89
Evidence against involvement of APC mutation in papillary thyroid carcinoma. Eur J Cancer (1994) 0.89
Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms. J Pathol (1990) 0.89
Role of BAX mutations in mismatch repair-deficient colorectal carcinogenesis. Oncogene (1999) 0.88
A cellular abnormality in glucocorticoid resistant asthma. Clin Exp Immunol (1985) 0.87
Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation. Oncogene (2000) 0.87
p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J (1997) 0.87
Caspase-mediated cleavage of APC results in an amino-terminal fragment with an intact armadillo repeat domain. FASEB J (1999) 0.87
Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer. Oncogene (1996) 0.86
Evaluation of a monoclonal antibody to ras peptide, RAP-5, claimed to bind preferentially to cells of infiltrating carcinomas. Br J Cancer (1986) 0.85
Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer. Br J Cancer (1996) 0.85
Enhancement of DNA-mediated gene transfer by high-Mr carrier DNA in synchronized CV-1 cells. Biochem J (1985) 0.85
Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation. J Pathol (1996) 0.84
Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. Br J Cancer (1995) 0.84
UV but not gamma-irradiation induces specific transcriptional activity of p53 in primary hepatocytes. J Pathol (1997) 0.84